Gaudium IVF IPO

Gaudium IVF IPO: Check IPO Date, Live Subscription and Key Details

Gaudium IVF & Women Health Ltd. is a leading fertility care provider in India specializing in In Vitro Fertilization (IVF) and assisted reproductive technologies (ART). Operating through a hub-and-spoke model with 7 hubs and 28 spokes, the company provides high-end fertility treatments and gynecological care. It is the first dedicated fertility services company to enter the Indian public markets, leveraging high-tech labs and medical tourism inflows.

Price Range
₹75.0 - ₹79.0
Issue Size
165 Cr
Lot Size
189 shares
IPO Type
Mainboard
GMP
8(+10.13%)
Est. Listing Price
₹87
Estimate Profit
₹1,512
Retail Portion
35.00%
Face Value
₹5
EPS
3.44
P/E Ratio
22.99
RoNW
41.71%
ROE
41.31%
Debt to Equity
0.41
Advertisement

Timeline

IPO Opens

20 Feb

IPO Closes

24 Feb

Allotment

25 Feb

Listing

27 Feb

IPO Timeline & Listing Details

EventDate
IPO Open Date20 February 2026
IPO Close Date24 February 2026
Allotment Date25 February 2026
Listing Date27 February 2026

Investment Categories

CategoryLotsAmount
Retail (Min)
1₹14,931
Retail (Max)Just less than ₹2,00,000
13₹1,94,103
SHNI (Min)Just above ₹2,00,000
14₹2,09,034
SHNI (Max)Below ₹10,00,000
66₹9,85,446
BHNIAbove ₹10,00,000
67₹10,00,377

IPO Reservation Details

CategoryReservation
QIB (Qualified Institutional Buyer)50.00%
NII (Non-Institutional Investor)15.00%
SHNI (Small Non-Institutional Investor)5.00%
BHNI (Big Non-Institutional Investor)10.00%
Retail35.00%
Total100.00%

IPO Objectives

  • Funding capital expenditure for establishment of 19 New IVF Centers (₹50.00 Cr).
  • Repayment or prepayment of certain outstanding loans (₹20.00 Cr).
  • General Corporate Purposes.

Strengths

  • The company benefits from a First-mover advantage as the first pure-play fertility services firm to be listed in the Indian market.
  • It demonstrates Exceptional Profitability, maintaining an EBITDA margin of approximately 40% and a robust RoNW of over 40%.
  • The business operates a Scalable Asset-Light Model through its hub-and-spoke infrastructure, allowing for efficient expansion.
  • It holds Strong Brand Value under the leadership of Dr. Manika Khanna, backed by over 10 years of clinical expertise and patient trust.

Weaknesses

  • The company faces a High Staff Attrition Risk, with reported turnover reaching 63% for FY25 among skilled doctors and embryologists.
  • There is significant Revenue Concentration, with over 75% of total income currently derived from the Delhi-NCR hub.
  • The business is subject to Regulatory Sensitivity, as any shifts in the Assisted Reproductive Technology (ART) Act or surrogacy laws could directly impact operations.
Advertisement

Financial Performance

Period Ended30 Sep 202531 Mar 202531 Mar 2024
Assets (₹ Cr.)106.6288.5151.01
Revenue (₹ Cr.)49.7570.9648.15
PAT (₹ Cr.)12.5119.1310.32
Net Worth (₹ Cr.)58.8546.326.99

Peer Comparison

CompanyP/B RatioP/E RatioRONW (%)Net Worth (₹ Cr.)
Gaudium IVF and Women10.4822.9941.71%58.85

Subscription Details

Daily Bids Status

CategoryDay 1
QIB0x
NII0.91x
S-HNI1.65x
B-HNI0.54x
RII1.42x
Total0.9x

Overall Subscription Statistics

CategoryShares OfferedShares BidBid Amount (₹ Cr)
QIB41,77,2402,6460.02
NII31,32,93028,49,17522.51
Small NII10,44,31017,19,71113.59
Big NII20,88,62011,29,4648.92
RII73,10,1701,03,44,15981.72
Total1,46,20,3401,31,95,980104.25
Advertisement

Company Details

  • Gaudium IVF & Women Health Ltd.
  • B1/51, Janak Puri, New Delhi, 110058
  • 011-4885 8585
  • compliance@gaudiumivfcentre.com
  • https://www.gaudiumivf.com/

Registrar Details

Frequently Asked Questions

What is the Gaudium IVF IPO price band?
The price band is set at ₹75 to ₹79 per equity share.
How much should I invest in Gaudium IVF IPO?
The minimum investment for retail investors is ₹14,931 for one lot of 189 shares.
What is the listing date of Gaudium IVF IPO?
The shares are expected to list on Feb 27, 2026.
Loading comments...